NSECopy of Newspaper Publication6d ago · 5 Nov 2026, 07:14 pm

Copy of Newspaper Publication

Aarti Drugs Limited · AARTIDRUGS

✦ AI SummaryResults

Aarti Drugs Limited has published its standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in accordance with SEBI regulations.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

Attachments (1)

📄

AARTIDRUGS_05112026191326_ADL.pdf

pdf

Download →
View document text
Ref: ADL/SE/2026-27/61 November 5, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Ref: Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Newspaper Publication of Financial Results In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith newspaper publication of Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2026, published in the following newspapers on Thursday, November 5, 2026: 1) Financial Express (English) 2) Pratahkal (Marathi) Plesda Kindly take the same on record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. No.: F12932 Published in Financial Express (English) on Thursday i.e. November 5, 2026 Published in Pratahkal (Marathi) on Thursday i.e. November 5, 2026